Craig Leonardi, MD, Saint Louis University, St. Louis, MO, United States; Steven R. Feldman, MD, PhD, Wake Forest University, Winston-Salem, NC, United States; Tiffani K Hamilton, MD, Atlanta Dermatology, Vein, and Research Center, Alpharetta, GA, United States; Seth R. Stevens, MD, Amgen, Inc., Thousand Oaks, CA, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Leonardi is a member of Amgen's clinical advisory board and speakers bureau and is a principal investigator in Amgen clinical trials. Dr. Feldman has received speaking, consulting, and grant support from Amgen. Dr. Hamilton has been a principal investigator in Amgen clinical trials and a member of Amgens speaker's bureau.
Research supported by Immunex Corporation, a wholly owned subsidiary of Amgen, Inc., and by Wyeth Research